NCT00165256
- Conditions
- Adenocarcinoma, Breast Carcinoma In Situ, Carcinoma, +7 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
Clinical trial condition
Explore clinical trials studying Carcinoma, Intraductal, Noninfiltrating. Study availability and eligibility vary by location and protocol.
NCT00165256
NCT01556243
NCT05900986
NCT00874458
NCT02928978
NCT06133647
NCT06982313
NCT06388304
NCT03664778
NCT03345420